BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 25008917)

  • 1. Effect of vaginal immunization with HIVgp140 and HSP70 on HIV-1 replication and innate and T cell adaptive immunity in women.
    Lewis DJ; Wang Y; Huo Z; Giemza R; Babaahmady K; Rahman D; Shattock RJ; Singh M; Lehner T
    J Virol; 2014 Oct; 88(20):11648-57. PubMed ID: 25008917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV vaccine trial exploits a dual and central role for innate immunity.
    Fuller DH; Richert-Spuhler LE; Klatt NR
    J Virol; 2014 Oct; 88(20):11640-3. PubMed ID: 25122775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innate and adaptive mucosal immunity in protection against HIV infection.
    Bergmeier LA; Lehner T
    Adv Dent Res; 2006 Apr; 19(1):21-8. PubMed ID: 16672545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel HIV-CCR5 receptor vaccine strategy in the control of mucosal SIV/HIV infection.
    Bogers WM; Bergmeier LA; Ma J; Oostermeijer H; Wang Y; Kelly CG; Ten Haaft P; Singh M; Heeney JL; Lehner T
    AIDS; 2004 Jan; 18(1):25-36. PubMed ID: 15090826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal HIV-1-gp160-DNA/gp41 peptide prime-boost immunization regimen in mice results in long-term HIV-1 neutralizing humoral mucosal and systemic immunity.
    Devito C; Zuber B; Schröder U; Benthin R; Okuda K; Broliden K; Wahren B; Hinkula J
    J Immunol; 2004 Dec; 173(11):7078-89. PubMed ID: 15557206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innate immunity and HIV-1 infection.
    Lehner T; Wang Y; Whittall T; Seidl T
    Adv Dent Res; 2011 Apr; 23(1):19-22. PubMed ID: 21441475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer T cell and TLR9 agonists as mucosal adjuvants for sublingual vaccination with clade C HIV-1 envelope protein.
    Singh S; Yang G; Byrareddy SN; Barry MA; Sastry KJ
    Vaccine; 2014 Dec; 32(51):6934-6940. PubMed ID: 25444819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination with the Conserved Caveolin-1 Binding Motif in Human Immunodeficiency Virus Type 1 Glycoprotein gp41 Delays the Onset of Viral Infection and Provides Partial Protection in Simian/Human Immunodeficiency Virus-Challenged Cynomolgus Macaques.
    Hovanessian AG; Soundaramourty C; Benferhat R; Le Grand R; Dereuddre-Bosquet N; Krust B; Estaquier J
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29976675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel mechanism linking memory stem cells with innate immunity in protection against HIV-1 infection.
    Wang Y; Whittall T; Neil S; Britton G; Mistry M; Rerks-Ngarm S; Pitisuttithum P; Kaewkungwal J; Nitayaphan S; Yu X; Sato A; O'Connell RJ; Michael NL; Robb ML; Kim JH; Lehner T
    Sci Rep; 2017 Apr; 7(1):1057. PubMed ID: 28432326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heat shock protein 70 enhances mucosal immunity against human norovirus when coexpressed from a vesicular stomatitis virus vector.
    Ma Y; Duan Y; Wei Y; Liang X; Niewiesk S; Oglesbee M; Li J
    J Virol; 2014 May; 88(9):5122-37. PubMed ID: 24574391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective mucosal immunity elicited by targeted lymph node immunization with a subunit SIV envelope and core vaccine in macaques.
    Lehner T; Wang Y; Cranage M; Bergmeier LA; Mitchell E; Tao L; Hall G; Dennis M; Cook N; Jones I; Doyle C
    Dev Biol Stand; 1998; 92():225-35. PubMed ID: 9554279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superiority in Rhesus Macaques of Targeting HIV-1 Env gp140 to CD40 versus LOX-1 in Combination with Replication-Competent NYVAC-KC for Induction of Env-Specific Antibody and T Cell Responses.
    Zurawski G; Shen X; Zurawski S; Tomaras GD; Montefiori DC; Roederer M; Ferrari G; Lacabaratz C; Klucar P; Wang Z; Foulds KE; Kao SF; Yu X; Sato A; Yates NL; LaBranche C; Stanfield-Oakley S; Kibler K; Jacobs B; Salazar A; Self S; Fulp W; Gottardo R; Galmin L; Weiss D; Cristillo A; Pantaleo G; Levy Y
    J Virol; 2017 May; 91(9):. PubMed ID: 28202751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCR5 targeted SIV vaccination strategy preventing or inhibiting SIV infection.
    Bogers WM; Bergmeier LA; Oostermeijer H; ten Haaft P; Wang Y; Kelly CG; Singh M; Heeney JL; Lehner T
    Vaccine; 2004 Aug; 22(23-24):2974-84. PubMed ID: 15356916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of cell surface CCR5 and CD40 molecules by their ligands or by HSP70 up-regulates APOBEC3G expression in CD4(+) T cells and dendritic cells.
    Pido-Lopez J; Whittall T; Wang Y; Bergmeier LA; Babaahmady K; Singh M; Lehner T
    J Immunol; 2007 Feb; 178(3):1671-9. PubMed ID: 17237417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of the extracellular domains of C-C chemokine receptor 5 and the in vitro effects on simian immunodeficiency virus or HIV infectivity.
    Lehner T; Doyle C; Wang Y; Babaahmady K; Whittall T; Tao L; Bergmeier L; Kelly C
    J Immunol; 2001 Jun; 166(12):7446-55. PubMed ID: 11390497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humoral immune responses by prime-boost heterologous route immunizations with CTB-MPR(649-684), a mucosal subunit HIV/AIDS vaccine candidate.
    Matoba N; Geyer BC; Kilbourne J; Alfsen A; Bomsel M; Mor TS
    Vaccine; 2006 Jun; 24(23):5047-55. PubMed ID: 16621185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal immunity and HIV-1 infection: applications for mucosal AIDS vaccine development.
    Belyakov IM; Ahlers JD
    Curr Top Microbiol Immunol; 2012; 354():157-79. PubMed ID: 21203884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative investigation of CC chemokines and SIV suppressor factors generated by CD8+ and CD4+ T cells and CD14+ monocytes.
    Babaahmady K; Bergmeier LA; Whittall T; Singh M; Wang Y; Lehner T
    J Immunol Methods; 2002 Jun; 264(1-2):1-10. PubMed ID: 12191503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel vaccination protocol with two live mucosal vectors elicits strong cell-mediated immunity in the vagina and protects against vaginal virus challenge.
    Li Z; Zhang M; Zhou C; Zhao X; Iijima N; Frankel FR
    J Immunol; 2008 Feb; 180(4):2504-13. PubMed ID: 18250460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rational basis for mucosal vaccination against HIV infection.
    Lehner T; Bergmeier L; Wang Y; Tao L; Mitchell E
    Immunol Rev; 1999 Aug; 170():183-96. PubMed ID: 10566151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.